Cardimed Asia Medikal

Cardimed Asia Medikal was founded in 2015 as an innovative medical technology company specializing in the field of cardiovascular medical devices. The company’s core product, the "Cardimed" artificial biological heart valve, is the first domestically produced bioprosthetic surgical valve to receive regulatory approval in China and is protected by independent intellectual property rights. Since its approval, the product has been clinically implanted in over 10,000 cases in China. Its resistance to calcification and durability have been thoroughly validated through clinical use. The product’s design performance and manufacturing processes meet international standards. It has been adopted by more than 250 hospitals across China, gradually breaking the monopoly of imported products in the artificial biological heart valve market.